Mosapride Tablets, whose correct name is Mosapride Citrate Tablets, treats patients with functional dyspepsia with heartburn, early satiety, belching, epigastric distension, nausea, and vomiting. The drug is a selective 5-HT4 receptor agonist that agonizes 5-HT4 receptors in the submucosal plexus of the digestive tract and promotes the release of acetylcholine, thus having a prokinetic effect on the upper gastrointestinal tract. Anticholinergics such as atropine have the potential to reduce the effectiveness of this drug, so it should be spaced out when combined. Taking Mosapride Citrate Tablets may have adverse reactions such as diarrhea, abdominal pain, skin rash and tiredness, dry mouth, dizziness and palpitations. It is contraindicated for those who are allergic to the drug; those with gastrointestinal bleeding, intestinal obstruction or perforation. After taking the drug for a period of time (usually 2 weeks), if there is no change in gastrointestinal symptoms, the drug should be discontinued. The safety of the drug has not been established in pregnant and lactating women and should be avoided. Use with caution in the elderly. If you need to use the drug patients, please under the guidance of a doctor or pharmacist, strictly follow the medical advice to take medication, do not self-medication.